These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33672395)

  • 61. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections.
    Powers JL
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S30-7. PubMed ID: 8878244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of the Efficacy of a Sublingual Bacterial Vaccine in the Prophylaxis of Recurrent Urinary Tract Infection.
    Carrión-López P; Martínez-Ruiz J; Librán-García L; Giménez-Bachs JM; Pastor-Navarro H; Salinas-Sánchez AS
    Urol Int; 2020; 104(3-4):293-300. PubMed ID: 31962327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Formulation factors affecting acceptability of oral medicines in children.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Kendall R; Tuleu C;
    Int J Pharm; 2015 Aug; 492(1-2):341-3. PubMed ID: 25959115
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.
    La Rosa M; Ranno C; André C; Carat F; Tosca MA; Canonica GW
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):425-32. PubMed ID: 10452766
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
    Serrano E; Wahn HU; Didier A; Bachert C
    Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Formulation and Evaluation of New Glimepiride Sublingual Tablets.
    Al-Madhagi W; Abdulbari Albarakani A; Khaled Alhag A; Ahmed Saeed Z; Mansour Noman N; Mohamed K
    J Pharm (Cairo); 2017; 2017():3690473. PubMed ID: 28261517
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial.
    Gunderson EW; Hjelmström P; Sumner M;
    Clin Ther; 2015 Oct; 37(10):2244-55. PubMed ID: 26412801
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The efficacy of oral piroxicam fast-dissolving tablets versus sublingual fentanyl in incident breakthrough pain due to bone metastases: a double-blinded randomized study.
    Yousef AA; Alzeftawy AE
    Support Care Cancer; 2019 Jun; 27(6):2171-2177. PubMed ID: 30306325
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Efficacy and safety of specific sublingual immunotherapy in children with allergic asthma and rhinitis].
    Chen HW; Chen YY; Bao ZL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):223-226. PubMed ID: 29871228
    [No Abstract]   [Full Text] [Related]  

  • 71. Medication use for pediatric upper respiratory tract infections.
    Das B; Sarkar C; Majumder AG
    Fundam Clin Pharmacol; 2006 Aug; 20(4):385-90. PubMed ID: 16867023
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sublingual immunotherapy in children and its potential beneficial collateral effect on respiratory tract infections.
    Occasi F; De Castro G; Zicari AM; Indinnimeo L; Tancredi G; Duse M
    Curr Med Res Opin; 2015 May; 31(5):939-41. PubMed ID: 25753228
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
    Nolte H; Maloney J
    Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation.
    Bayrak Z; Tas C; Tasdemir U; Erol H; Ozkan CK; Savaser A; Ozkan Y
    Eur J Pharm Biopharm; 2011 Aug; 78(3):499-505. PubMed ID: 21352916
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study.
    Esposito S; Bianchini S; Polinori I; Principi N
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30934539
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children.
    Lavonas EJ; Banner W; Bradt P; Bucher-Bartelson B; Brown KR; Rajan P; Murrelle L; Dart RC; Green JL
    J Pediatr; 2013 Nov; 163(5):1377-83.e1-3. PubMed ID: 23993129
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children.
    Kekitiinwa A; Musiime V; Thomason MJ; Mirembe G; Lallemant M; Nakalanzi S; Baptiste D; Walker AS; Gibb DM; Judd A
    Antivir Ther; 2016; 21(7):579-585. PubMed ID: 27128199
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Effective Allergenic Reactivity of House Dust Mite Sublingual Immunotherapy Tablets Is Determined by Tablet Formulation.
    Kito H; Du W; Nakazawa H; Lund K; Ohashi-Doi K
    Biol Pharm Bull; 2019; 42(6):1030-1033. PubMed ID: 31155578
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets.
    Bafail R; Rawas-Qalaji M; Rawas-Qalaji M; Aodah A
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1617-1623. PubMed ID: 31353966
    [No Abstract]   [Full Text] [Related]  

  • 80. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
    Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
    J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.